BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Diagnosis
26 results:

  • 1. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.
    Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043366
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between prior cancer diagnosis and osteoporosis: a matched case-control study.
    Yang S; Wang N; Wang J; Lix LM; Leslie WD; Yuan B
    Arch Osteoporos; 2022 Aug; 17(1):112. PubMed ID: 35960383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors.
    Katz AJ; Chen RC; Usinger DS; Danus SM; Zullig LL
    J Cancer Surviv; 2023 Apr; 17(2):351-359. PubMed ID: 35790675
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
    Peretti U; Cavaliere A; Niger M; Tortora G; Di Marco MC; Rodriquenz MG; Centonze F; Rapposelli IG; Giordano G; De Vita F; Stuppia L; Avallone A; Ratti M; Paratore C; Forti LG; Orsi G; Valente MM; Gaule M; Macchini M; Carrera P; Calzavara S; Simbolo M; Melisi D; De Braud F; Salvatore L; De Lorenzo S; Chiarazzo C; Falconi M; Cascinu S; Milella M; Reni M
    ESMO Open; 2021 Feb; 6(1):100032. PubMed ID: 33399070
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association between cancer-specific adverse event triggers and mortality: A validation study.
    Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent D; Lipitz-Snyderman A
    Cancer Med; 2020 Jun; 9(12):4447-4459. PubMed ID: 32285614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Results of the spanish section of the European Randomized Study of Screening for prostate cancer (ERSPC). Update after 21 years of follow-up.
    Luján Galán M; Páez Borda Á; Llanes González L; Romero Cajigal I; Berenguer Sánchez A
    Actas Urol Esp (Engl Ed); 2020; 44(6):430-436. PubMed ID: 32147352
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population.
    Rubio-Briones J; Borque-Fernando A; Esteban LM; Mascarós JM; Ramírez-Backhaus M; Casanova J; Collado A; Mir C; Gómez-Ferrer A; Wong A; Aragón F; Calatrava A; López-Guerrero JA; Groskopf J; Schalken J; Van Criekinge W; Domínguez-Escrig J
    Prostate; 2020 May; 80(6):500-507. PubMed ID: 32077525
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study.
    Huang GL; Kang CH; Lee WC; Chiang PH
    BMC Urol; 2019 Oct; 19(1):101. PubMed ID: 31660936
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of sociodemographic and clinical variables with time to start prostate cancer treatment.
    Sacramento RS; Simião LJ; Viana KCG; Andrade MAC; Amorim MHC; Zandonade E
    Cien Saude Colet; 2019 Sep; 24(9):3265-3274. PubMed ID: 31508747
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men.
    Moustsen IR; Larsen SB; Duun-Henriksen AK; Tjønneland A; Kjær SK; Brasso K; Johansen C; Dalton SO
    Br J Cancer; 2019 May; 120(11):1067-1074. PubMed ID: 31065112
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
    Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
    Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
    Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR).
    Nair-Shalliker V; Yap S; Nunez C; Egger S; Rodger J; Patel MI; O'Connell DL; Sitas F; Armstrong BK; Smith DP
    Int J Cancer; 2017 Feb; 140(3):565-574. PubMed ID: 27741552
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Commonest cancers in Pakistan - Findings and Histopathological Perspective from a Premier Surgical Pathology Center in Pakistan.
    Ahmad Z; Idrees R; Fatima S; Uddin N; Ahmed A; Minhas K; Memon A; Fatima SS; Arif M; Hasan S; Ahmed R; Pervez S; Kayani N
    Asian Pac J Cancer Prev; 2016; 17(3):1061-75. PubMed ID: 27039726
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.
    Pfister D; Porres D; Heidenreich A; Heidegger I; Knuechel R; Steib F; Behrendt FF; Verburg FA
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1410-7. PubMed ID: 26993315
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Lung transthoracic ultrasound elastography imaging and guided biopsies of subpleural cancer: a preliminary report.
    Sperandeo M; Trovato FM; Dimitri L; Catalano D; Simeone A; Martines GF; Piscitelli AP; Trovato GM
    Acta Radiol; 2015 Jul; 56(7):798-805. PubMed ID: 24951615
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.